227 related articles for article (PubMed ID: 31152240)
1. Chronic AICAR treatment prevents metabolic changes in cardiomyocytes exposed to free fatty acids.
Viglino C; Foglia B; Montessuit C
Pflugers Arch; 2019 Sep; 471(9):1219-1234. PubMed ID: 31152240
[TBL] [Abstract][Full Text] [Related]
2. A Role for Focal Adhesion Kinase in the Stimulation of Glucose Transport in Cardiomyocytes.
Viglino C; Montessuit C
J Cell Biochem; 2017 Apr; 118(4):670-677. PubMed ID: 27428469
[TBL] [Abstract][Full Text] [Related]
3. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.
Stuck BJ; Lenski M; Böhm M; Laufs U
J Biol Chem; 2008 Nov; 283(47):32562-9. PubMed ID: 18790741
[TBL] [Abstract][Full Text] [Related]
4. Crucial role for LKB1 to AMPKalpha2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes.
Habets DD; Coumans WA; El Hasnaoui M; Zarrinpashneh E; Bertrand L; Viollet B; Kiens B; Jensen TE; Richter EA; Bonen A; Glatz JF; Luiken JJ
Biochim Biophys Acta; 2009 Mar; 1791(3):212-9. PubMed ID: 19159696
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic Effects of Chronic Phorbol Ester Treatment to Improve Glucose Transport in Insulin-Resistant Cardiomyocytes.
Viglino C; Khoramdin B; Praplan G; Montessuit C
J Cell Biochem; 2017 Dec; 118(12):4716-4727. PubMed ID: 28513986
[TBL] [Abstract][Full Text] [Related]
6. 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside reduces glucose uptake via the inhibition of Na+/H+ exchanger 1 in isolated rat ventricular cardiomyocytes.
Ségalen C; Longnus SL; Baetz D; Counillon L; Van Obberghen E
Endocrinology; 2008 Apr; 149(4):1490-8. PubMed ID: 18187546
[TBL] [Abstract][Full Text] [Related]
7. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.
Chabowski A; Momken I; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
Mol Cell Biochem; 2006 Aug; 288(1-2):201-12. PubMed ID: 16710744
[TBL] [Abstract][Full Text] [Related]
8. Impaired stimulation of glucose transport in cardiac myocytes exposed to very low-density lipoproteins.
Papageorgiou I; Viglino C; Brulhart-Meynet MC; James RW; Lerch R; Montessuit C
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):614-622. PubMed ID: 27052924
[TBL] [Abstract][Full Text] [Related]
9. Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes.
Gaidhu MP; Perry RL; Noor F; Ceddia RB
Mol Endocrinol; 2010 Jul; 24(7):1434-40. PubMed ID: 20501641
[TBL] [Abstract][Full Text] [Related]
10. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Salt IP; Connell JM; Gould GW
Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
[TBL] [Abstract][Full Text] [Related]
11. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
14. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.
Russell RR; Bergeron R; Shulman GI; Young LH
Am J Physiol; 1999 Aug; 277(2):H643-9. PubMed ID: 10444490
[TBL] [Abstract][Full Text] [Related]
15. AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle.
Smith AC; Bruce CR; Dyck DJ
J Physiol; 2005 Jun; 565(Pt 2):537-46. PubMed ID: 15774530
[TBL] [Abstract][Full Text] [Related]
16. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of stimulated glucose transport by free fatty acids and PPARα or -δ agonists in cardiac myocytes.
Asrih M; Lerch R; Papageorgiou I; Pellieux C; Montessuit C
Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E872-84. PubMed ID: 22297301
[TBL] [Abstract][Full Text] [Related]
18. AICAR inhibits the Na+/H+ exchanger in rat hearts--possible contribution to cardioprotection.
Moopanar TR; Xiao XH; Jiang L; Chen ZP; Kemp BE; Allen DG
Pflugers Arch; 2006 Nov; 453(2):147-56. PubMed ID: 16983558
[TBL] [Abstract][Full Text] [Related]
19. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo.
Shearer J; Fueger PT; Rottman JN; Bracy DP; Martin PH; Wasserman DH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E871-7. PubMed ID: 15265760
[TBL] [Abstract][Full Text] [Related]
20. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
